Sitero Acquires Clario's eClinical Technology Suite
Sitero has announced its recent acquisition of a technology suite designed to manage the end-to-end clinical trial lifecycle. The newly acquired eClinical technology suite, formerly of Clario, will be integrated with Sitero's existing Mentor platform with plans to invest in AI to further streamline the clinical trial process. This combined suite offers tools designed to enhance efficiency, accuracy, and quality of data across the site, CRO, and sponsor lifecycle of clinical trials.
Key components of the technology platform include:
- Electronic Data Capture (EDC) and System
- Randomization and Trial Supply Management (RTSM)
- Clinical Trial Management System (CTMS)
- eTMF
- eConsent
- Site and Patient Payments
The Clario eClinical product suite will be rebranded and integrated into the Sitero Mentor platform. Sitero Mentor will continue to support the existing Clario customer base while further developing clinical solutions for new customers as well.
Reference
Sitero Acquires Clario's eClinical Technology Suite to Enhance Clinical Trial Delivery. (2023, August 1). Cision PR Newswire.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
First Patient Dosed in Phase III Trial of Enhertu as First-Line Treatment for Endometrial Cancer
June 10th 2025In combination with rilvegostomig or Keytruda, Enhertu will be evaluated versus chemotherapy in the DESTINY-Endometrial01 study for the treatment of patients with HER2-expressing, mismatch repair proficient primary advanced or recurrent endometrial cancer.
